Literature DB >> 21826117

Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.

Matthias T Stephan1, Darrell J Irvine.   

Abstract

Therapeutic treatments based on the injection of living cells are in clinical use and preclinical development for diseases ranging from cancer to cardiovascular disease to diabetes. To enhance the function of therapeutic cells, a variety of chemical and materials science strategies are being developed that engineer the surface of therapeutic cells with new molecules, artificial receptors, and multifunctional nanomaterials, synthetically endowing donor cells with new properties and functions. These approaches offer a powerful complement to traditional genetic engineering strategies for enhancing the function of living cells.

Entities:  

Year:  2011        PMID: 21826117      PMCID: PMC3148657          DOI: 10.1016/j.nantod.2011.04.001

Source DB:  PubMed          Journal:  Nano Today        ISSN: 1748-0132            Impact factor:   20.722


  176 in total

Review 1.  Applications of carrier erythrocytes in delivery of biopharmaceuticals.

Authors:  Mehrdad Hamidi; Adbolhossein Zarrin; Mahshid Foroozesh; Soliman Mohammadi-Samani
Journal:  J Control Release       Date:  2006-12-15       Impact factor: 9.776

2.  Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation.

Authors:  Elizabeth Chambers; Samir Mitragotri
Journal:  Exp Biol Med (Maywood)       Date:  2007-07

3.  Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation.

Authors:  D A Lawrence; R Song; P Weber
Journal:  J Leukoc Biol       Date:  1996-11       Impact factor: 4.962

4.  Changes of cell-surface thiols and intracellular signaling in human monocytic cell line THP-1 treated with diphenylcyclopropenone.

Authors:  Morihiko Hirota; Akira Motoyama; Mie Suzuki; Masashi Yanagi; Masato Kitagaki; Hirokazu Kouzuki; Shigenobu Hagino; Hiroshi Itagaki; Hitoshi Sasa; Saori Kagatani; Setsuya Aiba
Journal:  J Toxicol Sci       Date:  2010-12       Impact factor: 2.196

5.  Noncovalent cell surface engineering with cationic graft copolymers.

Authors:  John T Wilson; Venkata R Krishnamurthy; Wanxing Cui; Zheng Qu; Elliot L Chaikof
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

6.  Targeted delivery of progenitor cells for cartilage repair.

Authors:  James E Dennis; Nir Cohen; Victor M Goldberg; Arnold I Caplan
Journal:  J Orthop Res       Date:  2004-07       Impact factor: 3.494

7.  The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death.

Authors:  Fredrik B Thorén; Ana I Romero; Svante Hermodsson; Kristoffer Hellstrand
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

8.  Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.

Authors:  Africa Wallace; Veena Kapoor; Jing Sun; Paul Mrass; Wolfgang Weninger; Daniel F Heitjan; Carl June; Larry R Kaiser; Leona E Ling; Steven M Albelda
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

Review 9.  The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins.

Authors:  Margot G Paulick; Carolyn R Bertozzi
Journal:  Biochemistry       Date:  2008-06-17       Impact factor: 3.162

10.  Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.

Authors:  Lars Palmqvist; Nicolas Pineault; Carina Wasslavik; R Keith Humphries
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

View more
  62 in total

Review 1.  Synthetic cell surface receptors for delivery of therapeutics and probes.

Authors:  David Hymel; Blake R Peterson
Journal:  Adv Drug Deliv Rev       Date:  2012-02-25       Impact factor: 15.470

2.  Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Authors:  Matthias T Stephan; Sirkka B Stephan; Peter Bak; Jianzhu Chen; Darrell J Irvine
Journal:  Biomaterials       Date:  2012-05-15       Impact factor: 12.479

3.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

Review 4.  Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.

Authors:  Chengyi Tu; Subhamoy Das; Aaron B Baker; Janeta Zoldan; Laura J Suggs
Journal:  ACS Nano       Date:  2015-04-10       Impact factor: 15.881

Review 5.  Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery.

Authors:  Susheel Kumar Nethi; Shubhmita Bhatnagar; Swayam Prabha
Journal:  AAPS PharmSciTech       Date:  2021-03-08       Impact factor: 3.246

Review 6.  Enhancing cancer immunotherapy with nanomedicine.

Authors:  Darrell J Irvine; Eric L Dane
Journal:  Nat Rev Immunol       Date:  2020-01-31       Impact factor: 53.106

7.  Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.

Authors:  Rachael Mooney; Yiming Weng; Revathiswari Tirughana-Sambandan; Valerie Valenzuela; Soraya Aramburo; Elizabeth Garcia; Zhongqi Li; Margarita Gutova; Alexander J Annala; Jacob M Berlin; Karen S Aboody
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

8.  Click hybridization of immune cells and polyamidoamine dendrimers.

Authors:  Leyuan Xu; Olga Yu Zolotarskaya; W Andrew Yeudall; Hu Yang
Journal:  Adv Healthc Mater       Date:  2014-02-13       Impact factor: 9.933

9.  Cell-Surface Glyco-Engineering by Exogenous Enzymatic Transfer Using a Bifunctional CMP-Neu5Ac Derivative.

Authors:  Chantelle J Capicciotti; Chengli Zong; M Osman Sheikh; Tiantian Sun; Lance Wells; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2017-09-15       Impact factor: 15.419

Review 10.  Engineering Stem Cell Organoids.

Authors:  Xiaolei Yin; Benjamin E Mead; Helia Safaee; Robert Langer; Jeffrey M Karp; Oren Levy
Journal:  Cell Stem Cell       Date:  2016-01-07       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.